SR ONE CAPITAL MANAGEMENT, LP
CIK 0001910264 · REDWOOD CITY, CA · Quarter end: 2026-06-30 · Filed on: 2026-08-12 · Open the SEC source ↗
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$1.04B
2026 Q2
Positions
15
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
95.1%
Est. Net Flow (Q)
—
2026 Q2
Top Holdings
MANE
Veradermics, Inc.
28.4%
ZBIO
Zenas BioPharma, Inc
12.3%
CRSP
CRISPR Therapeutics AG
10.7%
AVLN
Avalyn Pharma, Inc
10.5%
DSGN
Design Therapeutics, Inc.
9.1%
ODTX
Odyssey Therapeutics, Inc.
6.8%
ALMS
Alumis Inc.
5.3%
ORIC
ORIC Pharmaceuticals, Inc.
4.8%
New / Increased
No prior quarter data
Reduced / Exited
No prior quarter data
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.